News
FDA approves blood test to detect Alzheimer’s disease
The test has a complicated name: The Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio. But the goal of the test, created by Fujirebio Diagnostics, is simple: Early detection of beta-amyloid plaques linked to the neurocognitive disease in adults 55 and older who are exhibiting signs and symptoms of the disorder.
Michelle Tarver, of the FDA's Center for Devices and Radiological Health, said: "Today's clearance is an important step for ...
Another study has added to the growing evidence linking the cold sore-causing herpes virus with Alzheimer’s disease. It also ...
Alzheimer’s is the seventh-leading cause of death among US adults, with the average patient living four to eight years after diagnosis.
The test will initially be available at about 50 American research institutes and hospitals that specialise in Alzheimer’s ...
A dementia expert has shed light on the signs and symptoms to be vigilant about. It's estimated that around a million people ...
A new UVA study finds that HIV drugs like NRTIs may reduce Alzheimer's risk by 10% annually, suggesting potential for ...
In a statement posted by the Massachusetts Institute of Technology Monday, researchers said they have used data about fruit ...
Symptomatic infection with the virus responsible for cold sores around the mouth–herpes simplex 1, or HSV-1 for short—may ...
Discover the surprising whole-body effects of Alzheimer's disease as evidence uncovers how brain proteins damage metabolism, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback